AR039185A1 - Celulas hospedantes que tienen propiedades mejoradas de supervivencia celular y metodos para generar estas celulas - Google Patents

Celulas hospedantes que tienen propiedades mejoradas de supervivencia celular y metodos para generar estas celulas

Info

Publication number
AR039185A1
AR039185A1 ARP030101098A ARP030101098A AR039185A1 AR 039185 A1 AR039185 A1 AR 039185A1 AR P030101098 A ARP030101098 A AR P030101098A AR P030101098 A ARP030101098 A AR P030101098A AR 039185 A1 AR039185 A1 AR 039185A1
Authority
AR
Argentina
Prior art keywords
cells
methods
host cells
hospeding
generate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Suspension/Interruption
Application number
ARP030101098A
Other languages
English (en)
Inventor
Heiko Meents
Fussenegger Martin Dr
Enenkel Barbara Dr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR039185A1 publication Critical patent/AR039185A1/es
Suspension/Interruption legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Células hospedantes de mamífero tratadas por ingeniería genética, que comprenden un nivel aumentado de genes anti-apoptosis activos y a métodos para generar estas células hospedantes. Más particularmente, la invención se refiere a métodos que modulan el nivel de genes activos anti-apoptosis en células hospedantes y células hospedantes que muestran una viabilidad celular aumentada retrasando / inhibiendo la muerte celular programada que se produce de forma natural en estas células. Reivindicación 1: Una célula hospedante de hámster genéticamente modificada mediante la introducción de secuencias de ácidos nucleicos que codifican un gen anti-apoptosis, un gen marcador amplificable y seleccionable y al menos un gen de interés.
ARP030101098A 2002-03-28 2003-03-28 Celulas hospedantes que tienen propiedades mejoradas de supervivencia celular y metodos para generar estas celulas Suspension/Interruption AR039185A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007144A EP1348758A1 (en) 2002-03-28 2002-03-28 Host cells having improved cell survival properties and methods to generate such cells

Publications (1)

Publication Number Publication Date
AR039185A1 true AR039185A1 (es) 2005-02-09

Family

ID=27798823

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101098A Suspension/Interruption AR039185A1 (es) 2002-03-28 2003-03-28 Celulas hospedantes que tienen propiedades mejoradas de supervivencia celular y metodos para generar estas celulas

Country Status (19)

Country Link
EP (2) EP1348758A1 (es)
JP (1) JP2005521406A (es)
KR (1) KR101080626B1 (es)
CN (1) CN1646683A (es)
AR (1) AR039185A1 (es)
AT (1) ATE459705T1 (es)
AU (1) AU2003222777A1 (es)
BR (1) BR0308810A (es)
CA (1) CA2480684C (es)
DE (1) DE60331529D1 (es)
DK (1) DK1490482T3 (es)
ES (1) ES2339760T3 (es)
IL (1) IL163599A0 (es)
MX (1) MXPA04009336A (es)
NZ (1) NZ536077A (es)
PE (1) PE20040166A1 (es)
TW (2) TWI332990B (es)
UY (1) UY27739A1 (es)
WO (1) WO2003083093A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002315534B2 (en) 2001-07-10 2008-05-22 Biogen Idec Inc. Inhibition of apoptosis process and improvement of cell performance
KR100454016B1 (ko) * 2002-01-05 2004-10-26 한국과학기술원 항예정사 유전자로 형질전환되고 ｄｈｆｒ 유전자가결핍된 신규한 ｃｈｏ 세포주, 그의 제조 방법 및 상기형질전환된 ｃｈｏ 숙주 세포를 이용한 목적단백질의 생산방법
JP2006503555A (ja) * 2002-06-26 2006-02-02 バイオジェン・アイデック・エムエイ・インコーポレイテッド タンパク質産生方法および使用するための改変細胞
WO2004062554A2 (en) * 2003-01-08 2004-07-29 Nsgene A/S Enhancement of dopaminergic neuron generation and survital
US7829306B2 (en) * 2003-10-24 2010-11-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Protein highly producing recombinant animal cell, method for preparing the same, and method for mass-producing protein using the same
US7531327B2 (en) * 2004-07-23 2009-05-12 Immunomedics, Inc. Methods and compositions for increasing longevity and protein yield from a cell culture
US7608425B2 (en) 2004-07-23 2009-10-27 Immunomedics, Inc. Methods for protein expression in mammalian cells in serum-free medium
US7537930B2 (en) 2004-07-23 2009-05-26 Immunomedics, Inc. Mammalian cell lines for increasing longevity and protein yield from a cell culture
EP1953222A1 (en) 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
EP2209891A1 (en) * 2007-11-13 2010-07-28 Boehringer Ingelheim Pharma GmbH & Co. KG Improving the secretory capacity in host cells
DK2331678T3 (en) * 2008-06-13 2015-10-12 Janssen Biotech Inc PROCEDURES FOR Gaining High-Viable Cell Density in Mammalian Cell Culture
US8962312B2 (en) 2008-07-23 2015-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Production host cell lines
CA2857640C (en) 2011-12-02 2021-11-16 Fate Therapeutics, Inc. Enhanced stem cell composition
CN104673754B (zh) * 2015-02-14 2018-03-02 百泰生物药业有限公司 重组骨髓瘤细胞克隆的筛选方法及由此获得的抗体分子
JP7214962B2 (ja) * 2018-01-17 2023-01-31 東ソー株式会社 アルカリホスファターゼ高発現動物細胞

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143291A (en) * 1995-05-04 2000-11-07 Us Navy Methods for modulating T cell survival by modulating bcl-XL protein level
AU5403100A (en) * 1999-06-08 2000-12-28 Novartis Ag Enforced expression of bcl-xl

Also Published As

Publication number Publication date
DK1490482T3 (da) 2010-07-05
DE60331529D1 (de) 2010-04-15
ATE459705T1 (de) 2010-03-15
EP1490482A1 (en) 2004-12-29
TWI332990B (en) 2010-11-11
TW201000633A (en) 2010-01-01
EP1490482B1 (en) 2010-03-03
KR20040099373A (ko) 2004-11-26
UY27739A1 (es) 2003-10-31
CA2480684A1 (en) 2003-10-09
CA2480684C (en) 2011-01-25
EP1348758A1 (en) 2003-10-01
ES2339760T3 (es) 2010-05-25
KR101080626B1 (ko) 2011-11-08
IL163599A0 (en) 2005-12-18
MXPA04009336A (es) 2005-01-25
CN1646683A (zh) 2005-07-27
JP2005521406A (ja) 2005-07-21
TW200307044A (en) 2003-12-01
PE20040166A1 (es) 2004-05-20
AU2003222777A1 (en) 2003-10-13
WO2003083093A1 (en) 2003-10-09
NZ536077A (en) 2006-04-28
BR0308810A (pt) 2005-06-28
TWI332991B (en) 2010-11-11

Similar Documents

Publication Publication Date Title
AR039185A1 (es) Celulas hospedantes que tienen propiedades mejoradas de supervivencia celular y metodos para generar estas celulas
Leigh et al. Model organisms for genetics in the domain Archaea: methanogens, halophiles, Thermococcales and Sulfolobales
BR0214366A (pt) construção de ácido nucleico recombinante, célula e, métodos para produzir ácido láctico, e para reduzir a atividade de piruvato descarboxilase em uma célula
DK1546174T3 (da) Fremgangsmåder og sammensætninger til RNA-interferens
CY1118167T1 (el) Πρωτογενη και εγγυς ηπατικα βλαστοκυτταρα
Pohlschroder et al. Haloferax volcanii
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
MX2008007286A (es) Ingenieria in vivo de superficie celular.
ATE537269T1 (de) Verfahren zur verbesserung der herstellung von isoprenoid-zusammensetzungen
WO2003080807A8 (en) Compositions and methods for suppressing eukaryotic gene expression
DE60327804D1 (de) Alanin-2,3-aminomutase
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
DE60310202D1 (de) Zielgerichtete chromosomale mutagenese mit zinkfingernukleasen
IL196893A0 (en) Site specific incorporation of non-natural amino acids by vertebrate cells
DE69841723D1 (de) Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
MX347112B (es) Composiciones y metodos para regular osmolaridad celular.
AR054599A1 (es) Proteccion de la proteina krp mutante negativa dominante contra una inhibicion activa del complejo cdk -ciclina por la krp de tipo salvaje
HK1101704A1 (en) Plasmid maintenance
WO2010065876A3 (en) Methods and compositions related to th-1 dendritic cells
BR112013015908A2 (pt) elemento de placa lateral aperfeiçoado como meio de ligação incluído em uma esteira transportadora sem-fim com empilhamento automático
Muranaka et al. Mechanism‐guided library design and dual genetic selection of synthetic OFF riboswitches
ES2461896B1 (es) Métodos para obtener plantas resistentes a sequía
DE60336124D1 (de) Gen-targeting mit replizierenden dna-molekülen
ATE527366T1 (de) Verfahren zur mischung von vielen heterologen genen
DE60323267D1 (en) Rna-bioassay

Legal Events

Date Code Title Description
FB Suspension of granting procedure